As the potential of GLP-1 agonists for addiction gains traction, big pharma is also starting to take notice, namely the two ...

It’s hard to turn on the TV these days without seeing ads for drugs like Ozempic, Wegovy, Zepbound or Mounjaro. These ...

For kidney transplant recipients with type 2 diabetes, use of glucagon-like peptide-1 receptor agonists was associated with ...

Blockbuster GLP-1 medications are changing patient care, impacting surgery volumes and reshaping the financial landscape of the healthcare industry.

How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...

Bacterial vaginosis affects nearly a third of women worldwide and can cause infertility, premature births and newborn deaths.

Beyond type 2 diabetes and weight loss, GLP-1 agonists can also help lower blood pressure, improve lipid disorders, reduce ...

The global antidiabetics market is on a strong growth trajectory, with sales projected to soar from USD 106.3 billion in 2024 to USD 298.2 billion by 2034. This substantial increase reflects a robust ...

Novo Nordisk’s GLP-1 drug Semaglutide, sold under brand names Ozempic and Wegovy, has been hailed as a miracle drug for ...

A new study reveals that anti-obesity drugs can help kidney transplant recipients with type 2 diabetes reduce the risk of ...

GLP-1 drugs include semaglutide, liraglutide and dulaglutide, now marketed as Ozempic, Wegovy, Saxenda, Victoza and Trulicity ...